Oh wow, absolutely holding through this weekend and next week. Emergency declared for the BEARS!
veritas.caute
Posts
-
-
bought after market at 24.xx not selling. A ten percent dividend is worth holding until this thing is up at least twenty bucks.
-
ten percent dividend that is.
-
This is a crazy deal... glad I found it so incredibly oversold. On the one hand you could flip it or just collect a crazy two percent dividend during the recession. Bought it after hours even cheaper than its close. 500 shares... no brainer. Will be back for more tomorrow if it does not bounce.
-
$CODX Here’s a news report about $CODX test kits https://youtu.be/k-U0EASyJXU
-
$HTBX check the chart on this one and zoom out - hold until over a dollar or there is something wrong with you. $HTBX has YEARS above this SP and only January 2020 dipped below the current price. $HTBX would be a solid hold WITHOUT the pandemic. With the pandemic it is insane to sell $HTBX at anything except a premium relative to its regular moving average. You can FOMO back in when we are at $1.50
-
It’s at 1699$
-
amazing - short massacre they are covering and buying to recoup losses
-
$IBIO has DARPA funding for rapid pandemic response - it is part of the department of defense reaction plan for pandemic preparedness.
This is a pandemic. DARPA funded this company in order to respond to this precise scenario. Do your own DD and enjoy the ride.
Indicators like DARPA funding and CEPI grants are how to distinguish between legitimate runners like $MRNA $INO $IBIO and pumps. CEPI grants and DARPA funding vs noise.
-
$INO has DARPA funding for rapid pandemic response - it is part of the department of defense reaction plan for pandemic preparedness.
This is a pandemic. DARPA funded this company in order to respond to this precise scenario. Do your own DD and enjoy the ride.
Indicators like DARPA funding and CEPI grants are how to distinguish between legitimate runners like $MRNA $INO $IBIO and pumps. CEPI grants and DARPA funding vs noise.
-
I can confirm that the protease inhibitors are demonstrated to have efficacy against SARS, MERS and are almost certainly to be used against SARS-2 (Covid-19)
$COCP can repurpose its entire HCV antiviral portfolio for use against nCoV-SARS-2
The market does not tend to do its own substantive medical research. Glad I am in before this ticker starts trending.
CODX
CODX
ENB
ENB
ENB
CODX
HTBX
AYTU
GOLD
GOLD
GOLD
IBIO
INO
INO
INO
IBIO
INO
COCP
INO
OPK